24 May 2013
Keywords: schering, ag, kicks, off, enrollment, ph, ii
Article | 07 March 2005
Schering AG of Germany has commenced recruitment of patients for a Phase II clinical trial of its angiogenesis inhibitor candidate ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 March 2005
23 May 2013
© 2013 thepharmaletter.com